BACKGROUND: Limited strategies have been developed to evaluate and address the alarming discrepancy in early mortality between Indigenous and non-Indigenous populations. OBJECTIVE: To assess heart failure (HF), HF risk factors and document cardiac characteristics in an Australian Aboriginal population. DESIGN, SETTING, PARTICIPANTS: Adults were enrolled across six Aboriginal communities in Central Australia. They undertook comprehensive cardiovascular assessments, including echocardiography, to determine HF status, asymptomatic ventricular dysfunction and underlying risk factor profile. RESULTS: Of 436 participants (mean age 44±14 years; 64% women) enrolled, 5.3% (95% CI 3.2% to 7.5%) were diagnosed with HF, only 35% of whom had a pre-existing HF diagnosis. Asymptomatic left ventricular dysfunction (ALVD) was seen in 13% (95% CI 9.4% to 15.7%) of the population. Estimates of HF risk factor prevalence were as follows: body mass index (BMI) ≥30 kg/m(2) 42%, hypertension 41%, diabetes mellitus 40%, coronary artery disease (CAD) 7% and history of acute rheumatic fever or rheumatic heart disease 7%. In logistic regression analysis (after adjustment for age and gender), HF was associated with CAD (OR=9.6, p<0.001), diabetes (OR=5.4, p=0.002), hypertension (OR=4.8, p=0.006), BMI ≥30 kg/m(2) (OR=2.9, p=0.02), acute rheumatic fever or rheumatic heart disease (OR=5.6, p=0.001) and B-type natriuretic peptide (OR=1.02, p<0.001). CONCLUSION: The burden of HF, ALVD and risk factors in this population was extremely high. This study highlights potentially modifiable targets on which to focus resources and screening strategies to prevent HF in this high-risk Indigenous population.
BACKGROUND: Limited strategies have been developed to evaluate and address the alarming discrepancy in early mortality between Indigenous and non-Indigenous populations. OBJECTIVE: To assess heart failure (HF), HF risk factors and document cardiac characteristics in an Australian Aboriginal population. DESIGN, SETTING, PARTICIPANTS: Adults were enrolled across six Aboriginal communities in Central Australia. They undertook comprehensive cardiovascular assessments, including echocardiography, to determine HF status, asymptomatic ventricular dysfunction and underlying risk factor profile. RESULTS: Of 436 participants (mean age 44±14 years; 64% women) enrolled, 5.3% (95% CI 3.2% to 7.5%) were diagnosed with HF, only 35% of whom had a pre-existing HF diagnosis. Asymptomatic left ventricular dysfunction (ALVD) was seen in 13% (95% CI 9.4% to 15.7%) of the population. Estimates of HF risk factor prevalence were as follows: body mass index (BMI) ≥30 kg/m(2) 42%, hypertension 41%, diabetes mellitus 40%, coronary artery disease (CAD) 7% and history of acute rheumatic fever or rheumatic heart disease 7%. In logistic regression analysis (after adjustment for age and gender), HF was associated with CAD (OR=9.6, p<0.001), diabetes (OR=5.4, p=0.002), hypertension (OR=4.8, p=0.006), BMI ≥30 kg/m(2) (OR=2.9, p=0.02), acute rheumatic fever or rheumatic heart disease (OR=5.6, p=0.001) and B-type natriuretic peptide (OR=1.02, p<0.001). CONCLUSION: The burden of HF, ALVD and risk factors in this population was extremely high. This study highlights potentially modifiable targets on which to focus resources and screening strategies to prevent HF in this high-risk Indigenous population.
Authors: Cesare Russo; Zhezhen Jin; Mitchell S V Elkind; Tatjana Rundek; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio Journal: Eur J Heart Fail Date: 2014-09-11 Impact factor: 15.534
Authors: Christopher X Wong; Anthony G Brooks; Yi-Han Cheng; Dennis H Lau; Geetanjali Rangnekar; Kurt C Roberts-Thomson; Jonathan M Kalman; Alex Brown; Prashanthan Sanders Journal: BMJ Open Date: 2014-10-24 Impact factor: 2.692
Authors: Berhe W Sahle; Alice J Owen; Mutsa P Mutowo; Henry Krum; Christopher M Reid Journal: BMC Cardiovasc Disord Date: 2016-02-06 Impact factor: 2.298
Authors: May Vawer; Patsy Kaina; Ann Leonard; Michael Ogata; Beth Blackburn; Malia Young; Todd B Seto Journal: Int J Circumpolar Health Date: 2013-08-05 Impact factor: 1.228
Authors: John A Woods; Judith M Katzenellenbogen; Patricia M Davidson; Sandra C Thompson Journal: BMC Cardiovasc Disord Date: 2012-11-01 Impact factor: 2.298
Authors: Tiew-Hwa Katherine Teng; Judith M Katzenellenbogen; Joseph Hung; Matthew Knuiman; Frank M Sanfilippo; Elizabeth Geelhoed; Dawn Bessarab; Michael Hobbs; Sandra C Thompson Journal: Int J Equity Health Date: 2015-08-12
Authors: Pupalan Iyngkaran; Nadarajan Kangaharan; Hendrik Zimmet; Margaret Arstall; Rob Minson; Merlin C Thomas; Peter Bergin; John Atherton; Peter MacDonald; David L Hare; John D Horowitz; Marcus Ilton Journal: Curr Cardiol Rev Date: 2016